Literature DB >> 8483055

Characterization of two monoclonal antibodies against secretory proteinase of Candida tropicalis DSM 4238.

M Borg-von Zepelin1, V Grüness.   

Abstract

Two murine IgM monoclonal antibodies (mAb; MT1 and MT2), which were produced against the secretory aspartic proteinase of Candida tropicalis DSM 4238, are described. Both antibodies reacted with the native and denatured conformations of the homologous proteinase antigen but showed different patterns of reactivity with other related proteinases (Candida albicans CBS 2730, serotype A; C. albicans ATCC 48867, serotype B; Candida parapsilosis DSM 4237) and with porcine pepsin. Neither of the antibodies inhibited the proteolytic activity of the homologous enzyme. MT1 also reacted with mannoproteins of C. tropicalis DSM 4238 and C. albicans CBS 2730 and immunofluorescence revealed that this antibody bound to the surface of blastoconidia and pseudomycelia of these two Candida species. A reaction with blastoconidia only was observed with C. albicans serotype B. MT1 also reacted weakly with Candida guilliermondii, but not with C. parapsilosis, Candida glabrata, Candida krusei or Candida kefyr. MT2 did not bind to fungal surfaces. Preliminary experiments suggested that mAb MT1 may recognize a carbohydrate epitope, while MT2 binds to an epitope consisting of the protein part of the enzyme. The two antibodies were used in an ELISA for the detection of proteinase antigen. ELISA with MT1 or MT2 as coating antibodies and a specific protein epitope recognizing mAb-biotin conjugate was able to detect 4 ng ml-1 of antigen. Trials with 26 sera from fungemic patients and 14 sera from controls suggest that MT2 is of potential value in antigen-directed serodiagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483055

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  8 in total

1.  Production, characterization, and epitope mapping of a monoclonal antibody against aspartic proteinase of Candida albicans.

Authors:  B K Na; G T Chung; C Y Song
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans.

Authors:  Françoise Dromer; Reynald Chevalier; Boualem Sendid; Luce Improvisi; Thierry Jouault; Raymond Robert; Jean Maurice Mallet; Daniel Poulain
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 3.  Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.

Authors:  M Kalin; B Petrini
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

4.  The role of somatic structure of the fungus Paracoccidioides brasiliensis upon B cell activation in experimental paracoccidioidomycosis.

Authors:  M F Silva; C L Silva
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 5.  The role of Candida albicans secreted aspartic proteinase in the development of candidoses.

Authors:  L Hoegl; M Ollert; H C Korting
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

6.  Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides.

Authors:  P A Trinel; M Borg-von-Zepelin; G Lepage; T Jouault; D Mackenzie; D Poulain
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients.

Authors:  M W Ollert; C Wende; M Görlich; C G McMullan-Vogel; M Borg-von Zepelin; C W Vogel; H C Korting
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis.

Authors:  Christine J Morrison; Steven F Hurst; Errol Reiss
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.